Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
41.17M | 44.69M | 46.59M | 53.43M | 62.53M | Gross Profit |
27.17M | 30.77M | 34.54M | 42.20M | 39.37M | EBIT |
-26.37M | -28.34M | -9.53M | 10.05M | -30.25M | EBITDA |
-14.30M | -12.12M | -5.47M | 20.20M | -33.67M | Net Income Common Stockholders |
-27.16M | -34.72M | -18.80M | 3.70M | -46.84M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.74M | 28.77M | 24.78M | 3.70M | 3.27M | Total Assets |
59.38M | 93.39M | 95.49M | 61.72M | 80.38M | Total Debt |
5.73M | 16.37M | 16.81M | 11.03M | 21.18M | Net Debt |
679.00K | -9.18M | -5.09M | 7.33M | 17.91M | Total Liabilities |
68.45M | 80.18M | 88.89M | 90.40M | 112.66M | Stockholders Equity |
-9.07M | 13.21M | 6.60M | -28.68M | -32.29M |
Cash Flow | Free Cash Flow | |||
-14.52M | -22.91M | -25.07M | 11.86M | -1.36M | Operating Cash Flow |
-14.41M | -19.01M | -23.07M | 12.26M | 1.57M | Investing Cash Flow |
-90.00K | -5.85M | -2.21M | 445.00K | 652.00K | Financing Cash Flow |
-5.65M | 28.57M | 43.46M | -12.34M | -11.79M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | HK$89.16M | 6.34 | 8.45% | 7.39% | -8.25% | -14.22% | |
66 Neutral | HK$1.29B | 17.30 | 12.85% | ― | 957.74% | 194.12% | |
61 Neutral | $6.68B | 11.75 | 3.01% | 3.94% | 2.61% | -21.96% | |
50 Neutral | HK$365.40M | ― | -6.91% | ― | 4.61% | 89.62% | |
49 Neutral | HK$21.48M | ― | -4.41% | ― | ― | ― | |
40 Underperform | HK$60.80M | ― | ― | -15.26% | 27.67% | ||
35 Underperform | HK$193.54M | ― | ― | -37.75% | -11.19% |